ReviewEndocrine, metabolic & immune disorders drug targets2026
Multi-system Mechanisms in the Anti-osteoporotic Effects of Herbal Natural Products.
Review in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOsteoporosis (OP) is increasingly recognized as a multi-system disorder beyond traditional hormonal and nutritional perspectives. This review aims to systematically present the therapeutic potential of natural components from Chinese medicine and herbal formulae, clarifying their mechanisms of action within human physiological systems.
methodsWe conducted a comprehensive search of relevant studies in PubMed, Web of Science, CNKI, and other databases. The focus was on the use of herbal monomers and classical formulas in the field of OP. This analysis focused on their multisystem interactions and their potential molecular pathways.
resultsOur analyses indicate that these natural products not only directly regulate bone metabolism through the Wnt/β-catenin, BMP/Smad, OPG/RANK/RANKL, and PI3K/AKT pathways, but they also exert anti-osteoporotic effects through multi-system regulatory mechanisms. Specifically, they exert therapeutic effects by: alleviating endocrine imbalances through regulating parathyroid hormone and estrogen levels; alleviating chronic inflammation via the NF-κB and MAPK pathways; regulating the composition of intestinal flora; and affecting nervous system signalling via sympathetic modulation. The herbal formulae particularly show synergistic effects when acting on multiple systems at the same time. DISCUSSION: The synthesis of evidence reveals that TCM counteracts OP via a holistic, system-restorative mechanism. By concurrently modulating endocrine, inflammatory, intestinal, and neural functions, this multi-system strategy addresses the complex etiology of OP and presents a complementary paradigm to conventional target therapies.
conclusionChinese medicine offers a multi-targeted treatment option for OP through restoring balance to the physiological system. This holistic treatment strategy, derived from TCM theory and increasingly validated by modern research, offers a promising complementary therapy for the treatment of OP. It can complement traditional single-targeted therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.